Study examines use of clinical and cost-effectiveness data for drug coverage decisions

A comparison of national agencies that play a role in determining drug coverage decisions in Britain, Canada and Australia finds that uncertainty regarding clinical effectiveness is a key issue in coverage decisions, with other factors including the ability to negotiate price and societal values, according to a study in the 7 October issue of JAMA...

Read the whole article on

More from